As of May 27
| +0.09 / +5.20%|
The 5 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +559.34% increase from the last price of 1.82.
The current consensus among 6 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.